Search research articles
Contact Us
Filters
Showing results (1171-1180 of 1,460) with videos related to
Page
of 146
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2022
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
Meagan McMahon, George O'Dell, Jessica Tan, et al.
The Journal of Infectious Diseases
|
September 17, 2014
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial
Uzma N Sarwar, Pamela Costner, Mary E Enama, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer
Jack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Leah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
NPJ Vaccines
|
April 20, 2023
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
Brooke Bollman, Naveen Nunna, Kapil Bahl, et al.
Sarcoma
|
June 19, 2023
Fibroblast Activation Protein Expression in Sarcomas
Jacquelyn N Crane, Danielle S Graham, Christine E Mona, et al.
Nature Communications
|
December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
Daiyin Tian, Michael B Battles, Syed M Moin, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
May 18, 2018
Surveillance for Lyme disease in Canada, 2009 to 2012
N H Ogden, J K Koffi, L R Lindsay, et al.
The Journal of Infectious Diseases
|
May 7, 2021
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans
Katherine E Burgomaster, Bryant M Foreman, Maya A Aleshnick, et al.
Journal of Virology
|
May 26, 2017
Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate
Bo Liang, Joan O Ngwuta, Sonja Surman, et al.
Page
of 146
Search research articles
Search
Showing results (1171-1180 of 1,460) with videos related to
Sort By:
Page
of 146
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2022
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
Meagan McMahon, George O'Dell, Jessica Tan, et al.
The Journal of Infectious Diseases
|
September 17, 2014
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial
Uzma N Sarwar, Pamela Costner, Mary E Enama, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer
Jack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Leah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
NPJ Vaccines
|
April 20, 2023
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
Brooke Bollman, Naveen Nunna, Kapil Bahl, et al.
Sarcoma
|
June 19, 2023
Fibroblast Activation Protein Expression in Sarcomas
Jacquelyn N Crane, Danielle S Graham, Christine E Mona, et al.
Nature Communications
|
December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
Daiyin Tian, Michael B Battles, Syed M Moin, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
May 18, 2018
Surveillance for Lyme disease in Canada, 2009 to 2012
N H Ogden, J K Koffi, L R Lindsay, et al.
The Journal of Infectious Diseases
|
May 7, 2021
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans
Katherine E Burgomaster, Bryant M Foreman, Maya A Aleshnick, et al.
Journal of Virology
|
May 26, 2017
Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate
Bo Liang, Joan O Ngwuta, Sonja Surman, et al.
Page
of 146